Log in

NYSE:EVHEvolent Health Stock Price, Forecast & News

$7.40
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.19
Now: $7.40
$7.50
50-Day Range
$5.53
MA: $7.04
$9.42
52-Week Range
$3.50
Now: $7.40
$12.01
Volume1.53 million shs
Average Volume1.70 million shs
Market Capitalization$632.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.68
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Read More
Evolent Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.94 out of 5 stars


Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
CUSIPN/A
Phone571-389-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$846.38 million
Cash Flow$2.36 per share
Book Value$10.98 per share

Profitability

Net Income$-301,970,000.00

Miscellaneous

Employees3,400
Market Cap$632.55 million
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Evolent Health (NYSE:EVH) Frequently Asked Questions

How has Evolent Health's stock been impacted by COVID-19 (Coronavirus)?

Evolent Health's stock was trading at $6.92 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EVH shares have increased by 6.9% and is now trading at $7.40. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Evolent Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Evolent Health.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Evolent Health.

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) issued its quarterly earnings data on Thursday, May, 7th. The technology company reported ($0.14) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. The technology company earned $247.29 million during the quarter, compared to analyst estimates of $239.35 million. Evolent Health had a negative net margin of 37.17% and a negative return on equity of 6.09%. View Evolent Health's earnings history.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its second quarter 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $236-247 million, compared to the consensus revenue estimate of $240.29 million.

What price target have analysts set for EVH?

11 brokers have issued 1 year price objectives for Evolent Health's shares. Their forecasts range from $8.00 to $18.00. On average, they anticipate Evolent Health's stock price to reach $13.20 in the next year. This suggests a possible upside of 78.3% from the stock's current price. View analysts' price targets for Evolent Health.

Has Evolent Health been receiving favorable news coverage?

News headlines about EVH stock have trended negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Evolent Health earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned headlines about the technology company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the near term. View the latest news about Evolent Health.

Who are some of Evolent Health's key competitors?

Some companies that are related to Evolent Health include R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL). View all competitors.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Energy Transfer LP Unit (ET), Netflix (NFLX), Micron Technology (MU), Advanced Micro Devices (AMD) and Aegean Marine Petroleum Network (ANW).

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
  • Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
  • Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
  • Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $7.40.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $632.55 million and generates $846.38 million in revenue each year. The technology company earns $-301,970,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Evolent Health employs 3,400 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.